Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M706991200 on October 8, 2007

J. Biol. Chem., Vol. 282, Issue 51, 36980-36986, December 21, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/51/36980    most recent
M706991200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ong, P. C.
Right arrow Articles by Pike, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ong, P. C.
Right arrow Articles by Pike, R. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

DNA Accelerates the Inhibition of Human Cathepsin V by Serpins*Formula

Poh Chee Ong{ddagger}1, Sheena McGowan{ddagger}1, Mary C. Pearce{ddagger}, James A. Irving{ddagger}§2, Wan-Ting Kan{ddagger}, Sergei A. Grigoryev3, Boris Turk||4, Gary A. Silverman**, Klaudia Brix{ddagger}{ddagger}5, Stephen P. Bottomley{ddagger}, James C. Whisstock, An NHMRC Principle Research Fellow and a Monash University Senior Logan Fellow. Joint senior author{ddagger}6, and Robert N. Pike, Joint senior author{ddagger}7

From the {ddagger}Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia, the §Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, United Kingdom, the Department of Biochemistry and Molecular Biology, Penn State University College of Medicine, Hershey, Pennsylvania 17033, the ||Department of Biochemistry and Molecular Biology, J. Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia, the **Newborn Medicine Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, and the {ddagger}{ddagger}School of Engineering and Science, Jacobs University Bremen, Campus Ring 6, D-28759 Bremen, Germany

A balance between proteolytic activity and protease inhibition is crucial to the appropriate function of many biological processes. There is mounting evidence for the presence of both papain-like cysteine proteases and serpins with a corresponding inhibitory activity in the nucleus. Well characterized examples of cofactors fine tuning serpin activity in the extracellular milieu are known, but such modulation has not been studied for protease-serpin interactions within the cell. Accordingly, we present an investigation into the effect of a DNA-rich environment on the interaction between model serpins (MENT and SCCA-1), cysteine proteases (human cathepsin V and human cathepsin L), and cystatin A. DNA was indeed found to accelerate the rate at which MENT inhibited cathepsin V, a human orthologue of mammalian cathepsin L, up to 50-fold, but unexpectedly this effect was primarily effected via the protease and secondarily by the recruitment of the DNA as a "template" onto which cathepsin V and MENT are bound. Notably, the protease-mediated effect was found to correspond both with an altered substrate turnover and a conformational change within the protease. Consistent with this, cystatin inhibition, which relies on occlusion of the active site rather than the substrate-like behavior of serpins, was unaltered by DNA. This represents the first example of modulation of serpin inhibition of cysteine proteases by a co-factor and reveals a mechanism for differential regulation of cathepsin proteolytic activity in a DNA-rich environment.


Received for publication, August 21, 2007 , and in revised form, October 5, 2007.

* This work was supported in part by the National Health and Medical Research Council (NHMRC) of Australia and the Australian Research Council (ARC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1.

1 Both authors contributed equally to this work.

2 An NHMRC C. J. Martin Postdoctoral Research Fellow.

3 Supported by National Institutes of Health Grant GM-59118.

4 Supported by grants from the Slovene Research Agency.

5 Supported by Deutsche Forschungsgemeinschaft Grant Br 1308/6-1, 6-2.

6 To whom correspondence may be addressed. Tel.: 61-3-99053747; Fax: 61-3-99054699; E-mail: james.whisstock{at}med.monash.edu.au. 7 To whom correspondence may be addressed. Tel.: 61-3-99053923; Fax: 61-3-99054699; E-mail: rob.pike{at}med.monash.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement